Quisinostat HCl

Overview

Quisinostat HCl is an inhibitor of histone deacetylase (HDAC) enzymes. HDAC inhibitors focus on HDAC enzymes, hindering the growth of cancer cells and triggering apoptosis, the programmed death of cancer cells. It also disrupts the HAT-dependent transcriptional repression complex in the nucleus to promote expression of genes involved in cellular proliferation. Reagent-grade; for laboratory research purposes only.

Application

Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API

Product Information

• Catalog No.: BP-40072
• CAS No.: 875320-31-3
• Molecular Formula: C21H26N6O2
• Molecular Weight: 394.5
• Storage: -20°C
• Availability: 24 Hours

Source

Original product source